Platelet Glycoprotein GPIIb-IIIa ComplexPlatelet Membrane GlycoproteinsPlatelet Aggregation InhibitorsImmunoglobulin Fab FragmentsBlood PlateletsPlatelet AggregationThrombastheniaAntigens, Human PlateletPlatelet ActivationAntibodies, MonoclonalHirudinsFibrinogenMyosin Type IIIBenzamidinesBleeding TimeHemorrhagePlatelet AdhesivenessMucopolysaccharidosis IIIPlatelet Glycoprotein GPIb-IX ComplexAngioplasty, Balloon, CoronaryAspirinHeparinFibrinolytic AgentsAnticoagulantsMyocardial InfarctionBlood Platelet DisordersAngina, UnstableTreatment OutcomeKanamycin KinaseThrombosisPeptidesTyrosineThrombocytopeniaCoronary ThrombosisAdenosine DiphosphateEnoxaparinTiclopidinevon Willebrand FactorNeoplasm StagingImmunoelectrophoresis, Two-DimensionalCarcinoma, Non-Small-Cell LungStentsPlatelet Function TestsAmidinesCombined Modality TherapyLung NeoplasmsGlycoproteinsDrug Therapy, CombinationPurpura, ThrombocytopenicOligopeptidesWhole Blood Coagulation TimePurpura, Thrombocytopenic, IdiopathicKluver-Bucy SyndromeAntithrombinsGlycogen Storage Disease Type IIIMolecular Sequence DataP-SelectinIntegrin alpha2PyrrolidinesSyndromePeptide FragmentsThrombinCoronary DiseaseMegakaryocytesReceptors, IgGAcute Coronary SyndromeAmino Acid SequenceIsoxazolesHepatitis A Virus, HumanEpitopesFractures, OpenAcute DiseaseSurvival RateSurvival AnalysisPlatelet CountBinding SitesTime FactorsRistocetinClot RetractionDouble-Blind MethodDual Specificity Phosphatase 2Recombinant ProteinsChemotherapy, AdjuvantRandomized Controlled Trials as TopicPipecolic AcidsHemorheologyHemorrhagic DisordersDose-Response Relationship, DrugInfusions, IntravenousMembrane ProteinsAntineoplastic Combined Chemotherapy ProtocolsProtein BindingUroplakin IIIGlycogen Debranching Enzyme SystemPolymorphism, GeneticImmunosorbent TechniquesSalmonella arizonaeMucopolysaccharidosesPneumonectomyProspective Studies